Download PDF
1 / Pages

Other users also viewed these articles

Chagas cardiomyopathy and heart failure: From epidemiology to treatment Érico Santos; Luiz Menezes Falcão;
Rev Port Cardiol. 2020;39:279-89
Impact of the creation of specialized units for patients with hypertrophic cardiomyopathy Martín Negreira-Caamaño; Jesús Piqueras-Flores; Inmaculada Vivo-Ortega; María Arántzazu-González-Marín; Manuel Muñoz-García; Alberto Jiménez-Lozano;
Rev Port Cardiol. 2021;40:221-3
SGLT-2 inhibitors: A step forward in the treatment of heart failure with reduced ejection fraction José Silva-Cardoso; Aurora Andrade; Dulce Brito; Jorge Ferreira; Cândida Fonseca; Marisa Peres; Fátima Franco; Brenda Moura;
Rev Port Cardiol. 2021;40:687-93